Skip to content

Checked

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

NCT04743141 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Recruiting
Phase
Phase 3
Interventional
Planned enrollment
600
Participants, all sites
U.S. sites
115
In 33 states

Study details

Conditions
Acute Treatment of Migraine
Sponsor
Pfizer (Industry)
Ages
6 to 17 years
Sex
All
Healthy volunteers
Not accepted
Start
04/28/2021
Primary completion (expected)
07/31/2030
Last updated by sponsor
09/24/2026

Full eligibility rules, contacts and site names: NCT04743141 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Arizona: Scottsdale, Tempe
  • California: Sacramento (3), Long Beach (2), Anaheim, Culver City, Fresno, La Jolla, North Hollywood, Pomona, San Bernardino, Upland, Walnut Creek
  • Colorado: Grand Junction (3), Aurora (2), Colorado Springs (2)
  • Connecticut: Cromwell, Stamford
  • District of Columbia: Washington D.C.
  • Florida: Miami (3), Orange Park, Orlando, Tampa, West Palm Beach
  • Georgia: Atlanta, Brunswick, Decatur
  • Illinois: Chicago, Naperville
  • Indiana: Westfield
  • Iowa: West Des Moines
  • Kansas: Kansas City
  • Kentucky: Lexington
  • Louisiana: New Orleans
  • Massachusetts: Waltham
  • Michigan: Grand Rapids (2), Ann Arbor, Kalamazoo, Royal Oak
  • Missouri: Ozark, Springfield
  • Montana: Missoula (3), Great Falls, Kalispell
  • Nebraska: Lincoln, Omaha
  • New Jersey: Neptune City (2)
  • New York: New York (5), Amherst, Commack, Port Jefferson Station
  • North Carolina: Charlotte, Greensboro
  • Ohio: Cincinnati (3), Cleveland, Dayton
  • Oklahoma: Oklahoma City
  • Oregon: Portland (2), Grants Pass
  • Pennsylvania: Philadelphia (2)
  • Rhode Island: East Greenwich
  • South Carolina: Greenville, Greer
  • Tennessee: Memphis (3), Clarksville, Nashville
  • Texas: Houston (5), Austin (3), Dallas (2), Bellaire, El Paso, Frisco, Plano
  • Utah: Salt Lake City (2)
  • Virginia: Charlottesville (3), Norfolk (2), Richmond
  • Washington: Seattle (2), Bellevue
  • Wisconsin: Madison

More studies on the same topic

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 09/24/2026